Children's Heart Center Vienna

The Pediatric Heart Center Vienna stands for the individual care of children and adolescents with congenital heart defects as well as acquired and genetic heart diseases. To ensure the best possible treatment for each individual patient, an experienced team of physicians from various disciplines is available around the clock. The multidisciplinary cooperation of pediatric cardiologists, cardiac surgeons, anesthesiologists and intensive care specialists enables first-class care through the implementation of innovative and optimized therapy concepts.

The comprehensive consultation of parents is a special concern of ours - also of parents whose children are already diagnosed with a heart defect during pregnancy. This enables us to plan the subsequent therapy in close cooperation with the treating gynecologist even before the birth.

Latest news

11. Juniortraining - October 18th - 19th 2024

Dear colleagues,
The 11th Juniortrining for interventions in congenital heart defects is taking place again this year. The congress program offers basic material science and radiation protection in the context of cardiac catheter examinations, with a focus on interventions in vitia. It includes lectures, interactive case studies and hands-on training on models and in simulation suites. Participants will have the opportunity to gain practical experience under the guidance of leading experts from Germany, Austria and Switzerland. The course is aimed at young doctors in further training in pediatric cardiology to make it easier for them to get started in invasive diagnostics and therapy. 

We look forward to your participation!

You can find the registration form for the course HERE. 

You can find more information HERE.

Dr Julian Heno receives this year's poster award of the AEPC Heart Failure and Heart Transplantation Working Group

The Pediatric Heart Transplantation research group at our Children's Heart Center was awarded a poster prize by the Working Group on Heart Failure and Heart Transplantation at this year's meeting of the European Association of Pediatric Cardiology (AEPC) in Porto. The research work deals with the potential use of the torque teno virus, which is detectable in almost all people and has no disease value. In future, the viral load could serve as a helpful marker for controlling immunosuppressive medication.

The link to the AEPC report can be found HERE.